Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • leekb
    Junior Member
    • Jul 2013
    • 7

    #1

    Fatty Liver Tissue ChIP Seq

    Hi all,

    I'm doing tissue ChIP seq using human liver tissue both in tumor and adjacent non tumor. I found that the liver tumor tissue always with so much fat/oil droplet and it seriously affect my ChIP so can't get enough DNA after pull down.

    Anyone can give me suggestions on how to deal with this problem? The tissues' weight always below 0.2g, I think trim the fat before ChIP not feasible as the fat stay inside the cells.

    And we interest in some TFs may not very abundant though.

    Thanks in advance!
  • doublestrand7
    Junior Member
    • Dec 2008
    • 2

    #2
    We have done lots of ChIP-Seq from liver and even from tumor and adjacent normal. These samples have never been a problem and never had problems with fat. If you can not get it to work Active Motif has an end-to-end ChIP-Seq service. http://www.activemotif.com/catalog/8...encing-service

    Comment

    • leekb
      Junior Member
      • Jul 2013
      • 7

      #3
      Originally posted by doublestrand7 View Post
      We have done lots of ChIP-Seq from liver and even from tumor and adjacent normal. These samples have never been a problem and never had problems with fat. If you can not get it to work Active Motif has an end-to-end ChIP-Seq service. http://www.activemotif.com/catalog/8...encing-service
      Hi doublestrand7,
      Nice to hear reply! Would you mind share a little bit more information about how many tissue you are using for IP? I'm doing AR ChIP-seq but sounds like not too much DNA pull down only 7ng using 50mg tissue both adj and tumor.

      Many thanks!

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...